Big Money Sentiment decreased to 0.93 in 2018 Q4. It has change of 0.06, from 2018Q3’s 0.99. The ratio fall due to Cardinal Health, Inc. positioning: 54 sold and 207 reduced. 87 funds amassed holdings and 155 increased holdings. Investors holded 258.08 million in 2018Q3 but now own 257.30 million shares or 0.30% less.
Pathstone Family Office Llc owns 0% invested in Cardinal Health, Inc. (NYSE:CAH) for 9 shs. Mariner Llc has 0.02% invested in Cardinal Health, Inc. (NYSE:CAH). Moreover, Paloma Mngmt Co has 0.19% invested in Cardinal Health, Inc. (NYSE:CAH). Advsrs Asset Mngmt reported 362,650 shs. Dekabank Deutsche Girozentrale has 252,664 shs for 0.07% of their capital. Eqis Cap Mgmt reported 0.11% stake. Manufacturers Life Insur The reported 297,112 shs or 0.02% of all its holdings. Robeco Institutional Asset Bv reported 399,259 shs or 0.08% of all its holdings. 13,260 are owned by Welch Forbes Llc. Moreover, Prelude Ltd Com has 0% invested in Cardinal Health, Inc. (NYSE:CAH). Brandes Invest Lp holds 1.86 million shs. Motco holds 0% of its capital in Cardinal Health, Inc. (NYSE:CAH) for 15 shs. Everett Harris And Com Ca invested 0.03% in Cardinal Health, Inc. (NYSE:CAH). World Asset Inc reported 0.07% stake. Bnp Paribas Asset Hldg Sa reported 99,647 shs stake.

Cardinal Health, Inc. had 1 sale and 0 buys since November 12, 2018. This’s net activity of $44,662.

Cardinal Health, Inc. (NYSE:CAH) declined significantly to $47.40. On Apr, 2 the move was reported by Barchart.com. It has $14.13B MC. At $45.50 price target, the company’s valuation could be $565.08M less.

Earnings report for Cardinal Health, Inc. (NYSE:CAH) is awaited on May, 2., as reported by Faxor. Analysts have expectation on stock’s earnings per share of $1.42. That’s up 2.16 % from last year’s $1.39 earnings per share. CAH’s profit could reach $423.21 million with 8.35 P/E in case $1.42 earnings per share is reported. After $1.29 earnings per share was reported previous quarter, analysts now see EPS growth of 10.08 % for Cardinal Health, Inc..

Cardinal Health, Inc. (NYSE:CAH) Ratings Coverage

A total of 3 analysts rate Cardinal Health (NYSE:CAH) as follows: 0 “Buy”, 2 “Hold” and 1 “Sell”. Тherefore 0 are bullish. (NYSE:CAH) has 3 ratings reports on Apr 2, 2019 according to StockzIntelligence. The company rating was downgraded by Leerink Swann on Friday, November 16. On Monday, December 3 Morgan Stanley maintained Cardinal Health, Inc. (NYSE:CAH) rating. Morgan Stanley has “Underweight” rating and $50 target.

For more Cardinal Health, Inc. (NYSE:CAH) news published recently go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “DOJ moves to strike down entire ACA – Seeking Alpha” published on March 26, 2019, “Walgreens Boots FQ2 weighs on drug wholesalers – Seeking Alpha” on April 02, 2019, “Cardinal Health: This Dividend Blue Chip Is Set To Deliver Alpha – Seeking Alpha” with a publish date: March 26, 2019, “Trump: Obamacare replacement will come after election – Seeking Alpha” and the last “CVS Health: High Risks, But Also A Great Investment Opportunity – Seeking Alpha” with publication date: March 08, 2019.

Cardinal Health, Inc. operates as an integrated healthcare services and products firm worldwide.The company has $14.13 billion market cap. The companyÂ’s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.Currently it has negative earnings. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers.